TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32453304

Group type: EXPERIMENTAL
Intervention: 1 session of plyometric training (1SPT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 2 sessions of plyometric training (2SPT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Plyometric training (PT)
Number of subjects: 30
Study: 33277203

Group type: EXPERIMENTAL
Intervention: Music medicine
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Skin contact with the newborn
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 150
Study: 32109257

Group type: EXPERIMENTAL
Intervention: Adaptable implementation package targeting risky prescribing
Number of subjects: 144

Group type: COMPARATOR
Intervention: Adaptable implementation package targeting diabetes control
Number of subjects: 144

Group type: COMPARATOR
Intervention: Adaptable implementation package targeting blood pressure control
Number of subjects: 144

Group type: COMPARATOR
Intervention: Adaptable implementation package targeting anticoagulation prescribing
Number of subjects: 144

Group type: COMPARATOR
Intervention: Adaptable implementation package targeting co-prescription of aspirin and clopidogrel without gastro-protection
Number of subjects: 144
Study: 33177324

Group type: EXPERIMENTAL
Intervention: Hydrocodone administration by parents with high anxiety
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Hydrocodone administration by parents with high stress
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Acetaminophen administration influenced by parental coping styles
Number of subjects: 173
Study: 616841895

Group type: EXPERIMENTAL
Intervention: LEEP
Number of subjects: 149

Group type: COMPARATOR
Intervention: CKC
Number of subjects: 149
Study: 35264345

Group type: EXPERIMENTAL
Intervention: Workplace intervention including 2-3 workshops, 2-3 consultative meetings with supervisors, follow-up meeting for the work unit, online meetings with supervisors.
Number of subjects: 450

Group type: COMPARATOR
Intervention: Control group (age-matched, sex-matched, occupation-matched) receiving no intervention.
Number of subjects: 450
Study: 32830383

Group type: EXPERIMENTAL
Intervention: Skin hygiene education and skills-training behavioral intervention (SKIN)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Usual care (informational brochure about substance use treatment options and needle exchange programs)
Number of subjects: 252
Study: 32799422

Group type: EXPERIMENTAL
Intervention: Point-of-care nerve conduction device (DPNCheck™)
Number of subjects: 375

Group type: COMPARATOR
Intervention: Nerve conduction study using a conventional electromyography system
Number of subjects: 375
Study: 36102565

Group type: EXPERIMENTAL
Intervention: Alvimopan
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 34001889

Group type: COMPARATOR
Intervention: Arm 1: Not contacted
Number of subjects: 80759

Group type: EXPERIMENTAL
Intervention: Arm 2: Follows current guidelines
Number of subjects: 80759

Group type: EXPERIMENTAL
Intervention: Arm 3: Follows a more intensive strategy
Number of subjects: 80759
Study: 33151928

Group type: EXPERIMENTAL
Intervention: Direct attitude
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Direct subjective norm
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Direct perceived behavioral control
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Indirect attitude
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Indirect perceived behavioral control
Number of subjects: 422
Study: 35769034

Group type: COMPARATOR
Intervention: Gepotidacin 100-3000 mg (single ascending doses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gepotidacin 400 mg twice daily to 2000 mg thrice daily (repeat ascending doses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gepotidacin 1500 mg twice daily (repeat doses in elderly)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gepotidacin with a moderate-fat meal
Number of subjects: 0
Study: 33089472

Group type: EXPERIMENTAL
Intervention: Viewing the Black patient
Number of subjects: 83

Group type: COMPARATOR
Intervention: Viewing the White patient
Number of subjects: 83
Study: 32505171

Group type: EXPERIMENTAL
Intervention: Low-dose glucose infusion (0.1 g/kg/hr. for 1 h followed by 0.05 g/kg/hr. for 1 h; LG group)
Number of subjects: 31

Group type: COMPARATOR
Intervention: No glucose infusion (0G group)
Number of subjects: 31
Study: 35896864

Group type: EXPERIMENTAL
Intervention: Less invasive surfactant administration (LISA)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Conventional endotracheal intubation (Control)
Number of subjects: 211
Study: 34505889

Group type: EXPERIMENTAL
Intervention: Regular expectation briefing
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: High expectation briefing
Number of subjects: 152

Group type: COMPARATOR
Intervention: Regular adverse side effect briefing
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Intense adverse side effect briefing
Number of subjects: 152
Study: 32115970

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (100 mg twice a day for seven days)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (standard treatment of sepsis)
Number of subjects: 40
Study: 35351936

Group type: EXPERIMENTAL
Intervention: Placebo induced expectation with oxytocin nasal spray
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Placebo induced expectation
Number of subjects: 0
Study: 33730455

Group type: EXPERIMENTAL
Intervention: Pegcetacoplan
Number of subjects: 80

Group type: COMPARATOR
Intervention: Eculizumab
Number of subjects: 80
Study: 35545155

Group type: EXPERIMENTAL
Intervention: INCREM intervention
Number of subjects: 52

Group type: COMPARATOR
Intervention: Psychoeducation programme
Number of subjects: 52

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 52
Study: 33513182

Group type: EXPERIMENTAL
Intervention: Late initiation of antenatal care (after 12 weeks of gestation)
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: Family size of ≥ 4
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: Maternal age ≥ 25 years
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: Perceived the right time of booking > 12 weeks of gestation
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: Not being a member of women's health developmental army
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: ANC not attended previously
Number of subjects: 389
Study: 32163677

Group type: EXPERIMENTAL
Intervention: Novel therapies (NT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Early radical cystectomy (ERC)
Number of subjects: 0
Study: 35033564

Group type: EXPERIMENTAL
Intervention: Education on Essential Newborn Care (ENC) through pictorial aids, demonstrations, and practice sessions
Number of subjects: 88

Group type: COMPARATOR
Intervention: Ongoing public health programs (control group)
Number of subjects: 88
Study: 33384385

Group type: EXPERIMENTAL
Intervention: SAFE intervention (five-session family therapy-based intervention delivered over 16 weeks)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 34
Study: 35079895

Group type: EXPERIMENTAL
Intervention: Raw corn starch
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Isomaltooligosaccharide (IMO)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: IMO/sucromalt combination
Number of subjects: 20

Group type: COMPARATOR
Intervention: Rapidly digestible carbohydrate control (maltodextrin)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Overall SDCs
Number of subjects: 20
Study: 35766659

Group type: EXPERIMENTAL
Intervention: Capillary refill time-targeted resuscitation based on clinical and hemodynamic phenotypes.
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Standard care (control group).
Number of subjects: 1500
Study: 32459669

Group type: EXPERIMENTAL
Intervention: Real-time visual feedback during overground walking training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no real-time visual feedback)
Number of subjects: 24
Study: 35863697

Group type: EXPERIMENTAL
Intervention: Summit program
Number of subjects: 64

Group type: COMPARATOR
Intervention: Pain tracking app (Control)
Number of subjects: 64
Study: 33512778

Group type: EXPERIMENTAL
Intervention: Total thyroidectomy + central lymph node dissection
Number of subjects: 2108

Group type: COMPARATOR
Intervention: Neck lateral lymph node dissection
Number of subjects: 2108
Study: 32804979

Group type: EXPERIMENTAL
Intervention: Early mobilization (EM)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control (standard care)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control (current guidelines)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control (evidence gap)
Number of subjects: 59
Study: 35732749

Group type: EXPERIMENTAL
Intervention: Mucosamin® oral spray
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 34072630

Group type: EXPERIMENTAL
Intervention: 60 mg of elemental iron as ferrous sulfate
Number of subjects: 376

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 376
Study: 34877531

Group type: EXPERIMENTAL
Intervention: Myomectomy
Number of subjects: 254

Group type: COMPARATOR
Intervention: Uterine artery embolization (UAE)
Number of subjects: 254
Study: 35929569

Group type: EXPERIMENTAL
Intervention: Diaphragm pacemaker and pulmonary rehabilitation therapies along with basic ICU nursing and conventional rehabilitation treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Basic ICU nursing and conventional rehabilitation treatment
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Diaphragm pacemaker and pulmonary rehabilitation therapies
Number of subjects: 40
Study: 33527332

Group type: EXPERIMENTAL
Intervention: Discontinuing PPIs (Group A)
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Replacement with H2 blockers (Group B)
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Continuing PPIs (Group C)
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: H2 blockers (Group D)
Number of subjects: 351

Group type: COMPARATOR
Intervention: Control group (Group E)
Number of subjects: 351
Study: 34511458

Group type: EXPERIMENTAL
Intervention: Integrated use of climatic‐, balneo‐ and focused magnetic therapy with anti‐tuberculosis chemotherapy
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Drinking mineral water 'Teberda' in addition to anti‐tuberculosis chemotherapy
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Focused magnetic therapy in addition to drinking mineral water 'Teberda' and anti‐tuberculosis chemotherapy
Number of subjects: 120

Group type: COMPARATOR
Intervention: Climatic‐ and anti‐tuberculosis chemotherapy (comparison group)
Number of subjects: 120
Study: 32532698

Group type: EXPERIMENTAL
Intervention: Nonpreferred music first, then preferred music
Number of subjects: 31

Group type: COMPARATOR
Intervention: Preferred music first, nonpreferred music second
Number of subjects: 31

Group type: COMPARATOR
Intervention: Overall comparison of preferred music vs nonpreferred music
Number of subjects: 31
Study: 33978284

Group type: EXPERIMENTAL
Intervention: Participants with MID
Number of subjects: 222

Group type: COMPARATOR
Intervention: Family members
Number of subjects: 222
Study: 35131017

Group type: EXPERIMENTAL
Intervention: Prophylactic DPC
Number of subjects: 62

Group type: COMPARATOR
Intervention: Non-prophylactic DPC
Number of subjects: 62
Study: 33737410

Group type: EXPERIMENTAL
Intervention: Co-amoxiclav 400/57 twice daily for 5 days
Number of subjects: 271

Group type: COMPARATOR
Intervention: Placebo twice daily for 5 days
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Co-amoxiclav 400/57
Number of subjects: 271

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 271
Study: 35687858

Group type: EXPERIMENTAL
Intervention: HP-3070 7.6 mg/24 h
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: HP-3070 3.8 mg/24 h
Number of subjects: 442

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 442
Study: 33145981

Group type: EXPERIMENTAL
Intervention: Out-of-pocket expenditure (OOPE) on direct medical and nonmedical goods and services
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Out-of-pocket expenditure on direct medical costs
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Out-of-pocket expenditure on direct nonmedical costs
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Direct medical expenditure
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Predictors of direct medical expenditure
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Predictors of direct nonmedical expenditure
Number of subjects: 130
Study: 35579077

Group type: EXPERIMENTAL
Intervention: Muscle mass phenotype grading system based on MUAMA and HGS
Number of subjects: 1660

Group type: EXPERIMENTAL
Intervention: Group 3 (worst muscle mass phenotype)
Number of subjects: 1660

Group type: EXPERIMENTAL
Intervention: MUAMA and HGS values
Number of subjects: 1660
Study: 32393279

Group type: EXPERIMENTAL
Intervention: Televisits via videoconference
Number of subjects: 202

Group type: COMPARATOR
Intervention: Standard in-person outpatient follow-up visits (control arm)
Number of subjects: 202
Study: 35171210

Group type: EXPERIMENTAL
Intervention: Off-pump CABG
Number of subjects: 2203

Group type: COMPARATOR
Intervention: On-pump CABG
Number of subjects: 2203
Study: 33890268

Group type: EXPERIMENTAL
Intervention: Aural Rehabilitation (AR) intervention consisting of auditory training and psychosocial counseling
Number of subjects: 25

Group type: COMPARATOR
Intervention: Active control group engaged in cognitive stimulation activities
Number of subjects: 25
Study: 32562206

Group type: EXPERIMENTAL
Intervention: Dabigatran dual therapy (110 or 150 mg twice daily, with clopidogrel or ticagrelor)
Number of subjects: 2678

Group type: COMPARATOR
Intervention: Warfarin triple therapy (with clopidogrel or ticagrelor, and aspirin for 1-3 months)
Number of subjects: 2678

Group type: EXPERIMENTAL
Intervention: Dabigatran dual therapy (110 or 150 mg)
Number of subjects: 2678

Group type: COMPARATOR
Intervention: Warfarin triple therapy
Number of subjects: 2678
Study: 34229263

Group type: EXPERIMENTAL
Intervention: Bifidobacterium breve BR03 (DSM 16604) and B. breve B632 (DSM 24706) at 2 × 10^9 CFU/AFU/day for 8 weeks
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 101
Study: 35300665

Group type: EXPERIMENTAL
Intervention: Yoga intervention (8 yoga sessions synced with anatomy topics)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Waitlist control group (normal anatomy curriculum, option to participate in yoga after course)
Number of subjects: 64
Study: 33754941

Group type: EXPERIMENTAL
Intervention: Microwave ablation (MWA)
Number of subjects: 552
Study: 32199339

Group type: COMPARATOR
Intervention: multisession transcranial direct current stimulation (tDCS)
Number of subjects: 101
Study: 35901367

Group type: EXPERIMENTAL
Intervention: Engagement-focused parent-teen treatment (STAND)
Number of subjects: 854

Group type: EXPERIMENTAL
Intervention: Community-based usual care
Number of subjects: 854

Group type: EXPERIMENTAL
Intervention: Summer Treatment Program-Adolescent (STP-A)
Number of subjects: 854

Group type: EXPERIMENTAL
Intervention: Standard behavioral parent training + organization skills training (BPT/OST)
Number of subjects: 854

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 854

Group type: EXPERIMENTAL
Intervention: BPT/OST and STP-A
Number of subjects: 854

Group type: EXPERIMENTAL
Intervention: STAND, BPT/OST, and STP-A
Number of subjects: 854

Group type: COMPARATOR
Intervention: Parent contingency management and disruptive classroom behavior
Number of subjects: 854
Study: 33412896

Group type: EXPERIMENTAL
Intervention: Comprehensive Self‐Management (CSM) intervention including dietary education and cognitive behavioral therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 30
Study: 35162195

Group type: EXPERIMENTAL
Intervention: Nutritional Support System (NSS)
Number of subjects: 80
Study: 32864754

Group type: COMPARATOR
Intervention: Tetramethylpyrazine nitrone (TBN) 50-1800 mg IV infusion over 30 min (SAD study)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Tetramethylpyrazine nitrone (TBN) 700 or 1400 mg twice daily for 6.5 days (MAD study)
Number of subjects: 92
Study: 33380585

Group type: EXPERIMENTAL
Intervention: Pectoral nerve block with 10 mL of 2% lignocaine as an initial bolus followed by 10 mL every 8 hours up to 24 hours (Group I)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No regional block (Group II)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Pectoral nerve block (Group I)
Number of subjects: 20
Study: 35579420

Group type: EXPERIMENTAL
Intervention: 3-D models of echocardiographic imaging planes
Number of subjects: 39

Group type: COMPARATOR
Intervention: Self-explanatory text about echocardiographic imaging planes (control group)
Number of subjects: 39
Study: 34059372

Group type: EXPERIMENTAL
Intervention: Vaccines For Babies (VFB) intervention
Number of subjects: 250

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 250
Study: 32848377

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Cognitive Training (Control)
Number of subjects: 28
Study: 34716885

Group type: EXPERIMENTAL
Intervention: Reminiscence therapy involved care (RTIC)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 152
Study: 33323886

Group type: EXPERIMENTAL
Intervention: Psychological intervention administered by a psychiatrist before surgery and ongoing thereafter
Number of subjects: 49

Group type: COMPARATOR
Intervention: Routine TKA care without psychological interventions
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Psychological intervention
Number of subjects: 49
Study: 35748086

Group type: EXPERIMENTAL
Intervention: Leaflet resection
Number of subjects: 104

Group type: COMPARATOR
Intervention: Leaflet preservation
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 104
Study: 34264305

Group type: EXPERIMENTAL
Intervention: Celecoxib 400 mg once daily for 2 years
Number of subjects: 2639

Group type: COMPARATOR
Intervention: Placebo once daily for 2 years
Number of subjects: 2639
Study: 36180067

Group type: EXPERIMENTAL
Intervention: ActivOnline (AO)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 107
Study: 34452956

Group type: EXPERIMENTAL
Intervention: Eltrombopag
Number of subjects: 162

Group type: COMPARATOR
Intervention: Standard first-line management
Number of subjects: 162
Study: 33302648

Group type: EXPERIMENTAL
Intervention: Polyethylene glycol 4000, 10 g, twice daily
Number of subjects: 113

Group type: COMPARATOR
Intervention: Lactulose, 15 mL, twice daily
Number of subjects: 113
Study: 34986170

Group type: EXPERIMENTAL
Intervention: Zvandiri peer counselling with problem-solving therapy (PST)
Number of subjects: 842

Group type: COMPARATOR
Intervention: Standard Zvandiri care (control)
Number of subjects: 842
Study: 33044356

Group type: EXPERIMENTAL
Intervention: Trazodone 50 mg daily for 5 days
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 33294980

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg
Number of subjects: 85

Group type: COMPARATOR
Intervention: Rosuvastatin 20 mg
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Both atorvastatin and rosuvastatin
Number of subjects: 85
Study: 32911474

Group type: EXPERIMENTAL
Intervention: Fluoride Varnish (FV)
Number of subjects: 1284

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 1284
Study: 33063321

Group type: EXPERIMENTAL
Intervention: Online self-compassion resources
Number of subjects: 248

Group type: COMPARATOR
Intervention: Waitlist-control
Number of subjects: 248
Study: 33112518

Group type: EXPERIMENTAL
Intervention: Open surgical approach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Minimally invasive technique
Number of subjects: 0
Study: 35121700

Group type: EXPERIMENTAL
Intervention: Oxcarbazepine (900-2400 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sodium valproate (about 20 mg/kg/day)
Number of subjects: 0
Study: 33663021

Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation (PMR) exercises, 28 min sessions, three times a week for 8 weeks
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (no PMR intervention)
Number of subjects: 49
Study: 33814236

Group type: EXPERIMENTAL
Intervention: Lp(a)
Number of subjects: 1030836

Group type: EXPERIMENTAL
Intervention: LDL-cholesterol
Number of subjects: 1030836

Group type: EXPERIMENTAL
Intervention: HDL-cholesterol
Number of subjects: 1030836

Group type: EXPERIMENTAL
Intervention: Triglycerides
Number of subjects: 1030836

Group type: EXPERIMENTAL
Intervention: ApoA1
Number of subjects: 1030836

Group type: EXPERIMENTAL
Intervention: ApoB
Number of subjects: 1030836
Study: 32130025

Group type: EXPERIMENTAL
Intervention: Angiotensin II infusion for 7 hours at night
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (saline) infusion for 7 hours at night
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Angiotensin II infusion
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (saline) infusion
Number of subjects: 11
Study: 35861588

Group type: EXPERIMENTAL
Intervention: Spesolimab (300 mg single dose; 450 mg every 4 weeks; or 1,200 mg every 4 weeks, three doses)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Spesolimab
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 36282078

Group type: EXPERIMENTAL
Intervention: L-arginine (0.1 mg.kg‐1 daily)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sildenafil (0.25 mg.kg‐1 two times a day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (Conventional thalassemia and PHT management)
Number of subjects: 60
Study: 35300246

Group type: EXPERIMENTAL
Intervention: Trimodal therapy followed by gemcitabine plus cetuximab maintenance (Arm B)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Trimodal therapy followed by gemcitabine maintenance (Arm A)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Trimodal therapy consisting of IMRT, gemcitabine and cetuximab
Number of subjects: 68
Study: 32208443

Group type: COMPARATOR
Intervention: Chest compression depth target of 'approximately 4 cm' (Group A)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Chest compression depth target of 'at least one-third the anterior-posterior diameter of the chest' (Group B)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Two-thumb technique (TT) with 'at least one-third the anterior-posterior diameter of the chest' (Group B)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Two-thumb technique (TT) with 'approximately 4 cm' (Group A)
Number of subjects: 40